Literature DB >> 25378087

Occult bacteraemia is uncommon in febrile infants who appear well, and close clinical follow-up is more appropriate than blood tests.

Susanna Hernandez-Bou1, Victoria Trenchs, Astrid Batlle, Amadeu Gene, Carles Luaces.   

Abstract

AIM: The rate of paediatric occult bacteraemia after the introduction of the 13-valent pneumococcal conjugated vaccine is relatively unknown. We determined the rate, and identified isolated pathogens, in children aged three to 36 months who presented to a paediatric emergency department with fever, but otherwise appeared well. We also analysed the yield of laboratory parameters traditionally considered risk factors for occult bacteraemia.
METHODS: Children aged three to 36 months who were febrile, but otherwise appeared well, were included if they had blood tests in the paediatric emergency department between April 2010 and September 2012.
RESULTS: Of the 591 patients, only six (1.0%) had a true bacterial pathogen and three of those were Streptococcus pneumoniae (0.5%). None of the children with pneumococcal bacteraemia had been immunised. The contaminant rate was 2.7%, and an elevated band count was the best predictor of occult bacteraemia, with positive and negative likelihood ratios of 10 and 0.4, respectively. The yield of the other laboratory parameters was very limited.
CONCLUSION: In the era of the 13-valent pneumococcal conjugated vaccine, occult bacteraemia is an uncommon event in febrile children aged three to 36 who otherwise appear well and close follow-up should replace blood analysis in such cases. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Emergency department; Fever without source; Infants; Occult bacteraemia; Pneumococcal conjugated vaccine

Mesh:

Year:  2015        PMID: 25378087     DOI: 10.1111/apa.12852

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.

Authors:  Susanna Hernández-Bou; Borja Gómez; Santiago Mintegi; Juan J García-García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-07       Impact factor: 3.267

2.  Evaluation of the bedside Quikread go® CRP test in the management of febrile infants at the emergency department.

Authors:  S Hernández-Bou; V Trenchs; M I Vanegas; A F Valls; C Luaces
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-03       Impact factor: 3.267

3.  Etiology, Treatment, and Outcome of Children Aged 3 to 36 Months With Fever Without a Source at a Community Hospital in Southern Thailand.

Authors:  Nonthapan Phasuk; Awirut Nurak
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

4.  The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization.

Authors:  Eugene Leibovitz; Nuphar David; Haya Ribitzky-Eisner; Mouner Abo Madegam; Said Abuabed; Gabriel Chodick; Michal Maimon; Yariv Fruchtman
Journal:  Int J Environ Res Public Health       Date:  2016-07-19       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.